<- Go Home

Medpace Holdings, Inc.

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Market Cap

N/A

Volume

398.4K

Cash and Equivalents

$652.7M

EBITDA

$591.0M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$1.9B

Profit Margin

71.90%

52 Week High

$628.92

52 Week Low

N/A

Dividend

N/A

Price / Book Value

20.08

Price / Earnings

26.45

Price / Tangible Book Value

N/A

Enterprise Value

N/A

Enterprise Value / EBITDA

18.14

Operating Income

$562.9M

Return on Equity

77.25%

Return on Assets

17.47

Cash and Short Term Investments

$652.7M

Debt

$146.1M

Equity

$598.3M

Revenue

$2.7B

Unlevered FCF

$490.7M

Sector

Life Sciences Tools and Services

Category

N/A

Company Stock Pitches